CLINICAL_TRIALS
trial_result
· 2014-09-01
Clinical Trial Update: Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine [Phase 4]
Summary
A Phase 4 trial evaluated immunogenicity and safety of two doses of a live attenuated varicella vaccine. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Changchun Keygen Biological Products Co., Ltd. | Conditions: Varicella | Phase 4 | Status: COMPLETED